Connection

William Hrushesky to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications William Hrushesky has written about Breast Neoplasms.
William Hrushesky
Connection Strength
2.700
Breast Neoplasms
  1. Global breast cancer seasonality. Breast Cancer Res Treat. 2010 Aug; 123(1):233-43.
    View in: PubMed
    Score: 0.172
  2. Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst. 2007 Jul 04; 99(13):1053; author reply 1053-4.
    View in: PubMed
    Score: 0.144
  3. Enhanced surgery-induced angiogenesis among premenopausal women might partially explain excess breast cancer mortality of blacks compared to whites: an hypothesis. Int J Surg. 2007 Oct; 5(5):300-4.
    View in: PubMed
    Score: 0.139
  4. Screening and breast cancer. N Engl J Med. 2006 Feb 16; 354(7):767-9; author reply 767-9.
    View in: PubMed
    Score: 0.131
  5. Sex cycle modulates cancer growth. Breast Cancer Res Treat. 2005 May; 91(1):95-102.
    View in: PubMed
    Score: 0.124
  6. Re: Melatonin and breast cancer: a prospective study. J Natl Cancer Inst. 2004 Jun 02; 96(11):888-9.
    View in: PubMed
    Score: 0.116
  7. Breast cancer screening: controversies and future directions. Curr Opin Obstet Gynecol. 2003 Feb; 15(1):1-8.
    View in: PubMed
    Score: 0.106
  8. Fertility cycle influence on surgical breast cancer cure. Breast Cancer Res Treat. 2002 Sep; 75(1):65-72.
    View in: PubMed
    Score: 0.103
  9. Breast cancer screening for women aged 40-49 years: screening may not be the benign process usually thought. J Natl Cancer Inst. 2001 Oct 17; 93(20):1572.
    View in: PubMed
    Score: 0.097
  10. Wounding from biopsy and breast-cancer progression. Lancet. 2001 Mar 31; 357(9261):1048.
    View in: PubMed
    Score: 0.093
  11. Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res Treat. 2001 Feb; 65(3):217-24.
    View in: PubMed
    Score: 0.092
  12. Interpreting Breast Cancer Survival Data by the Hazard Function: Remarkable Findings from Event Dynamics. Medicina (Kaunas). 2020 Sep 12; 56(9).
    View in: PubMed
    Score: 0.090
  13. Rhythmic menstrual cycle modulation of breast cancer biology. J Surg Oncol. 2000 Jul; 74(3):238-41.
    View in: PubMed
    Score: 0.089
  14. Menstrual timing of breast cancer surgery. Am J Surg. 1998 Mar; 175(3):245-61.
    View in: PubMed
    Score: 0.075
  15. Menstrual cycle timing of breast cancer resection. Recent Results Cancer Res. 1996; 140:27-40.
    View in: PubMed
    Score: 0.065
  16. Square pegs in round holes. Int J Cancer. 1995 Sep 04; 62(5):651-2.
    View in: PubMed
    Score: 0.063
  17. Menstrual cycle timing of breast cancer resection: prospective study is overdue. J Natl Cancer Inst. 1995 Jan 18; 87(2):143-4.
    View in: PubMed
    Score: 0.061
  18. Breast cancer and the menstrual cycle. J Surg Oncol. 1993 May; 53(1):1-3.
    View in: PubMed
    Score: 0.054
  19. Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review. Curr Med Chem. 2013; 20(33):4163-76.
    View in: PubMed
    Score: 0.053
  20. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012 Jul; 134(2):881-8.
    View in: PubMed
    Score: 0.050
  21. Optimal timing of initial breast cancer surgery. Ann Intern Med. 1992 Feb 01; 116(3):268.
    View in: PubMed
    Score: 0.049
  22. The effect of surgical timing within the fertility cycle on breast cancer outcome. Ann N Y Acad Sci. 1991; 618:277-91.
    View in: PubMed
    Score: 0.046
  23. Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast. BMC Cancer. 2010 Nov 30; 10:656.
    View in: PubMed
    Score: 0.046
  24. Menstrual influence on surgical cure of breast cancer. Lancet. 1990 Apr 21; 335(8695):984.
    View in: PubMed
    Score: 0.044
  25. Menstrual influence on surgical cure of breast cancer. Lancet. 1989 Oct 21; 2(8669):949-52.
    View in: PubMed
    Score: 0.042
  26. Menstrual history and breast cancer surgery. Breast Cancer Res Treat. 1989 Jul; 13(3):278.
    View in: PubMed
    Score: 0.041
  27. Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer. BMC Cancer. 2009 Jan 08; 9:7.
    View in: PubMed
    Score: 0.040
  28. Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS. 2008 Jul-Aug; 116(7-8):730-41.
    View in: PubMed
    Score: 0.039
  29. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat Clin Pract Oncol. 2007 Dec; 4(12):699-710.
    View in: PubMed
    Score: 0.037
  30. Racial disparities in breast cancer outcome: insights into host-tumor interactions. Cancer. 2007 Nov 01; 110(9):1880-8.
    View in: PubMed
    Score: 0.037
  31. Comment to "Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782. Ann Surg Oncol. 2007 Apr; 14(4):1519-20.
    View in: PubMed
    Score: 0.035
  32. Allometric scaling law questions the traditional mechanical model for axillary lymph node involvement in breast cancer. J Clin Oncol. 2006 Sep 20; 24(27):4391-6.
    View in: PubMed
    Score: 0.034
  33. Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005. Breast Cancer Res Treat. 2006 Jun; 97(3):341-3.
    View in: PubMed
    Score: 0.033
  34. Comment to Jatoi et al. report. Breast Cancer Res Treat. 2005 Sep; 93(1):1-2.
    View in: PubMed
    Score: 0.032
  35. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol. 2005 Sep; 16(9):1449-57.
    View in: PubMed
    Score: 0.031
  36. Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer. 2005 Mar; 41(4):508-15.
    View in: PubMed
    Score: 0.030
  37. Recent translational research: computational studies of breast cancer. Breast Cancer Res. 2005; 7(1):37-40.
    View in: PubMed
    Score: 0.030
  38. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour. Breast Cancer Res. 2004; 6(6):R689-96.
    View in: PubMed
    Score: 0.030
  39. Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients. Breast Cancer Res. 2004; 6(4):R372-4.
    View in: PubMed
    Score: 0.029
  40. Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening. J Clin Oncol. 2004 Jan 01; 22(1):102-7.
    View in: PubMed
    Score: 0.028
  41. Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract. 2017 06; 13(6):e562-e573.
    View in: PubMed
    Score: 0.018
  42. The multifrequency (circadian, fertility cycle, and season) balance between host and cancer. Ann N Y Acad Sci. 1991; 618:228-56.
    View in: PubMed
    Score: 0.011
  43. The effects of surgery on tumor growth: a century of investigations. Ann Oncol. 2008 Nov; 19(11):1821-8.
    View in: PubMed
    Score: 0.010
  44. The clinical application of chronobiology to oncology. Am J Anat. 1983 Dec; 168(4):519-42.
    View in: PubMed
    Score: 0.007
  45. Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity. Jpn J Cancer Res. 2001 Mar; 92(3):328-36.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.